Drug Self-Administration Report Prospectus

7/31/2019 Drug Self-Administration Report Prospectus

http://slidepdf.com/reader/full/drug-self-administration-report-prospectus 1/5

Drug Self-Administration

to 2016

Devices, Drugs, Markets, Strategies

and Forecasts

Greystone Research

associates

Report Prospectus



Greystone Research Associates is pleased to announce the publication of a new market

study. Drug Self-Administration Markets to 2016: Devices, Drugs, Markets, Strategies

and Forecasts is a comprehensive evaluation and analysis of the technology, products

demographics, prescribing trends, and participants providing the driving force behind

this evolving segment of the drug delivery sector.

The study is designed to provide drug company decision makers, drug deliverydevelopers, device designers, healthcare marketers, and supply chain participants with a

detailed understanding of the economics, technologies, disease segments, and

commercial opportunities for self-administration of non-oral drugs. Provider

organization business managers, healthcare administrators and investors will also

benefit from this study.

Evolving Technology and Tailored Delivery Devices

A number of factors are converging to create both risk and opportunity for drug makers

and their delivery device partners. These include new classes of drugs for previouslyrefractory conditions, growing trend toward self-administration for chronic diseases,

shifting patient demographics in industrial countries, caregiver safety legislation, and

continued pressure to control healthcare costs. These factors are giving rise to a new

generation of sophisticated, application-specific injection, inhalation and transdermal

drug products designed to satisfy caregiver and patient preferences while addressing

managed care initiatives and the formulation limitations of new classes of therapeutic

drugs. Because of their ability to safely and reliably satisfy treatment protocols and

compliance goals, non-oral drug delivery products will have a significant impact on the

future of drug self-administration.

Managed CareManagers

ManagementConsultants

FinancialAnalysts

ProductDevelopers

ComponentSuppliers

CMOs, CSOs

Pharma ProductManagers

Device Suppliers

BiotechManagers

Drug Marketers

& Strategists ClinicalManagers

Drug Distributors

PharmaRegulators

Report Value Matrix

D

r u g S e l f - A d m i n i s

t r a t i o n t

o

2 0 1 6



Executive Summary

Drug Market Dynamics

Evolving Drug Market Factors

Chronic Disease and Self-administration

Managed Care and Prescribing Trends

Drug Self-Administration Demand Factors

Shifting Patient DemographicsBiological Drug Proliferating

Delivery Device Technology & Evolving

Drug Self-Administration Product Segments and

Market Drivers

Injectable Drug Self-Administration Products

Market Sector Dynamics

The Shift to Prefilled Devices

Device Selection Factors

Market Segmentation & Cost

Product Features & Ease of UseCustom Device Designs & Branding

Prefilled Syringes (PFS)

Glass PFS

Plastic PFS

Prospects for Autoinjector s

Key PFS Therapeutic Segments

The PFS Supply Chain

PFS Supplier Profiles

Pen Injectors

Reusable Pens

Disposable Pens

Key Pen Injector Therapeutic Segments

The Top Ten Pen Injector Drug Products

Five Segments Driving Pen Injector GrowthPen Injector Company Profiles

Needle-free Injectors (NFI)

Reusable NFI

Disposable

Competitive NFI Therapeutic Segments

Needle-free Company Profiles

Inhaled Drug Self-Administration Products


The Upper Respiratory Market

Established Therapeutic Targets

Dual Drug InhalersThe Systemic/Deep Lung Market

Established Markets

Emerging Therapies

Inhaler Technology and Market Prospects

Inhaler Product Segments

Dry Powder Inhalers

Device Design Factors

Powder Technology

Packaging Issues

DPI Device Company Profiles

Metered Dose Inhalers

Basic Designs

Breathe Actuated Designs

MDI Device Company Profiles

Nebulizers

Established Nebulizer Therapies

Evolving Nebulizer TechnologyNebulizer Device Company Profiles

Performance Factors

Bioavailability

Dose Reproducibility

Active Compound Stability

Transdermal Drug Products


Traditional Patch Markets

Emerging Markets

Transdermal Patch Market Drivers

Prescription Patch Design & TechnologyPassive Patch Architecture

Passive Transdermal Patch Design

Passive Patch Construction

Active Transport Patch Technologies

Iontophoresis

Electroporation

Microporation

Mechanical Arrays

Radio Frequency

Thermal/Heat

Ultrasound

Prescription Patch Development Factors

Key Transdermal Therapeutic Markets

Transdermal Product Company Profiles

Drug Self-Administration – Therapeutic Sector

Analysis & Forecasts

ADHD

Anticoagulants

Arthritis

Asthma/COPD

Cardiovascular

Contraception

Cystic Fibrosis

Diabetes

HematopoieticsHepatitis

Hormone Therapy/Replacement

Multiple Sclerosis

Neurology

Osteoporosis

Pain Management

Psoriasis

Sexual Health

D

r u g S e l f -

A d m i n i s t r a t i o n t o

2 0 1 6

Table of Contents



Feature Summary

• Provides detailed analysis of drug self-administration market segments, market dynamicsand market demographics

• Analyzes therapeutic demand drivers and evaluates commercial drug products in morethan two dozen major self-administration therapeutic segments

• Analyzes design factors, material selection issues, technologies and market developmentissues for injection devices, inhalation devices and transdermal drug products designed forself-administration

• Charts product data, market share, and forecasts to 2016• Profiles self-administration drug product and device participants, their product

development activities, business strategies, and corporate alliances and affiliations• Assesses the importance of pharma-device alliances and design partnerships on drug self-

administration commercialization• Evaluates the impact of economic, technology, and regulatory factors

Report Format and Availability

This report is available in electronic format. A site license for a single physical location

and an Enterprise license are also available.

Methodology

Research methodology is based on primary research in the form of in-depth interviews withkey market participants, technology developers, distributors, industry experts, and marketinfluencers, a list that includes regulatory officials, industry trade groups, and materialsstandards organizations.

Primary data is evaluated and normalized against secondary sources including tradejournal articles, technical literature, industry publications, company data sheets and

published information, and statistical data from government agencies and tradeassociations.

Forecasts and projections of market demand and future market activity are derived usingstandard modeling and statistical techniques.

About Greystone Research Associates

Greystone Research Associates is a medical technology consulting firm focused on the

areas of medical market strategy, product commercialization, venture development, and

market research. We assist medical and healthcare market participants in achieving theirbusiness objectives through the creation of detailed development strategies, product

commercialization programs, and comprehensive market and technology research and

analysis.

Our market research publications are designed, researched and written to provide timelyand insightful information and data on focused market segments, with the aim of providingmarket participants with the essential knowledge to refine and execute their marketingplans and financial targets.

D r u g S e l f - A d m i n i s t r a t i o n

t o

2 0 1 6



Ordering Information

Orders may be placed via postal mail, e-mail or fax. Orders not accompanied by a purchase order must contain a telephone number

for verification, and clearly indicate the physical shipping address. Orders which are not prepaid must indicate the billing address.

There is no charge for handling and shipping for destination addresses within the continental US.

Payment We accept the following forms of payment:Company Check : Please make checks payable to ‘Greystone Associates’

Credit Cards: We accept MasterCard, Visa and American Express

Wire Transfers: See ’Wire Transfers’ below for more information

Orders Outside the U.S.

Orders must be prepaid via credit card, company check in US funds and drawn on a US bank, or wire transfer. There is a $50per copy shipping and handling charge for international shipments.

Wire Transfers:TD Banknorth

300 Franklin StreetManchester, NH 03103

(Call for Account Information)

Mailing Address:Greystone Research Associates

Client ServicesP.O. Box 1362Amherst, NH 03031

98 Route 101A • P .O. Box 1362 • Amherst, NH 03031 • 603-595-4340 • (F) 603-218-7020 • [email protected]

Drug Self-Administration to 2016

Select Format Price (U.S. funds) Total

Electronic $4,850.00

Site License $6,500.00

Enterprise License $9,500.00Total Payment (U.S. funds)

Method of Payment: ___ Company Check ___ ___ ___ ___ Wire Transfer (International)

Card Number:___________________________ Name on Card ________________________________________

Expiration Date: ____________ Card CVV_______ Signature ___________________________________

Billing Information Shipping Information

Click here if same as Billing Information

Name: Name:

Title: Title:

Company: Company:

Street Address: Street Address:

City,State/Province: City,State/Province:

Country/Postal Code: Country/Postal Code:

Phone: Phone:

Fax: Fax:

Email: Email:

How To Order

Documents

Drug Self-Administration Report Prospectus